wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34763374-596FF855-3ADB-448C-A256-10893D4A220A
Q34763374-596FF855-3ADB-448C-A256-10893D4A220A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34763374-596FF855-3ADB-448C-A256-10893D4A220A
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial.
P2860
Q34763374-596FF855-3ADB-448C-A256-10893D4A220A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34763374-596FF855-3ADB-448C-A256-10893D4A220A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a10bd58e585ce711306f1ae154eeeeed4aa8eb1
P2860
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure